{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T19:58:21Z","timestamp":1762113501344},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2014,12,11]],"date-time":"2014-12-11T00:00:00Z","timestamp":1418256000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0003391","type":"journal-article","created":{"date-parts":[[2014,12,11]],"date-time":"2014-12-11T20:05:50Z","timestamp":1418328350000},"page":"e3391","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["DNA-Protein Immunization Using Leishmania Peroxidoxin-1 Induces a Strong CD4+ T Cell Response and Partially Protects Mice from Cutaneous Leishmaniasis: Role of Fusion Murine Granulocyte-Macrophage Colony-Stimulating Factor DNA Adjuvant"],"prefix":"10.1371","volume":"8","author":[{"given":"Abebe Genetu","family":"Bayih","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nada S.","family":"Daifalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lashitew","family":"Gedamu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,12,11]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"J Alvar","year":"2012","journal-title":"PloS one"},{"key":"ref2","article-title":"The leishmaniases and Leishmania\/HIV co-infections","volume":"116","year":"2000","journal-title":"Fact Sheet"},{"key":"ref3","unstructured":"WHO (2007) Report of the fifth consultative meeting on Leishmania\/HIV coinfection. Addis Ababa, Ethiopia: WHO. 1\u201332 p."},{"key":"ref4","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.pt.2006.09.004","article-title":"Leishmaniasis and poverty","volume":"22","author":"J Alvar","year":"2006","journal-title":"Trends in parasitology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3389\/fimmu.2012.00128","article-title":"Protective immunity and vaccination against cutaneous leishmaniasis","volume":"3","author":"I Okwor","year":"2012","journal-title":"Frontiers in immunology"},{"key":"ref6","first-page":"423","article-title":"Leishmaniasis vaccine candidates for development: a global overview","volume":"123","author":"A Khamesipour","year":"2006","journal-title":"Indian J Med Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"10816","DOI":"10.1074\/jbc.M212990200","article-title":"Role of peroxidoxins in Leishmania chagasi survival. Evidence of an enzymatic defense against nitrosative stress","volume":"278","author":"SD Barr","year":"2003","journal-title":"The Journal of biological chemistry"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"34279","DOI":"10.1074\/jbc.M104406200","article-title":"Cloning and characterization of three differentially expressed peroxidoxin genes from Leishmania chagasi. Evidence for an enzymatic detoxification of hydroxyl radicals","volume":"276","author":"SD Barr","year":"2001","journal-title":"The Journal of biological chemistry"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.actatropica.2006.08.001","article-title":"Identification, sequencing and expression of peroxidoxin genes from Leishmania aethiopica","volume":"99","author":"D Jirata","year":"2006","journal-title":"Acta tropica"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1128\/EC.5.5.861-870.2006","article-title":"Expression of a mitochondrial peroxiredoxin prevents programmed cell death in Leishmania donovani","volume":"5","author":"S Harder","year":"2006","journal-title":"Eukaryotic cell"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1128\/IAI.66.7.3279-3289.1998","article-title":"Human and murine immune responses to a novel Leishmania major recombinant protein encoded by members of a multicopy gene family","volume":"66","author":"JR Webb","year":"1998","journal-title":"Infect Immun"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1128\/IAI.63.2.472-477.1995","article-title":"Protection of gerbils from amebic liver abscess by immunization with recombinant Entamoeba histolytica 29-kilodalton antigen","volume":"63","author":"CJ Soong","year":"1995","journal-title":"Infect Immun"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1128\/IAI.69.6.4103-4108.2001","article-title":"Protection against cutaneous leishmaniasis induced by recombinant antigens in murine and nonhuman primate models of the human disease","volume":"69","author":"A Campos-Neto","year":"2001","journal-title":"Infect Immun"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1128\/IAI.70.6.2828-2836.2002","article-title":"Vaccination with plasmid DNA encoding TSA\/LmSTI1 leishmanial fusion proteins confers protection against Leishmania major infection in susceptible BALB\/c mice","volume":"70","author":"A Campos-Neto","year":"2002","journal-title":"Infect Immun"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1182\/blood.V88.1.202.202","article-title":"Granulocyte-macrophage colony-stimulating factor: an effective adjuvant for protein and peptide-based vaccines","volume":"88","author":"ML Disis","year":"1996","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/sj.cr.7310017","article-title":"Granulocyte-macrophage colony-stimulating factor (GM-CSF) and T-cell responses: what we do and don&apos;t know","volume":"16","author":"Y Shi","year":"2006","journal-title":"Cell research"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.4049\/jimmunol.161.5.2325","article-title":"A plasmid encoding murine granulocyte-macrophage colony-stimulating factor increases protection conferred by a malaria DNA vaccine","volume":"161","author":"WR Weiss","year":"1998","journal-title":"Journal of immunology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/infdis\/jir199","article-title":"Prevention of infection by a granulocyte-macrophage colony-stimulating factor co-expressing DNA\/modified vaccinia Ankara simian immunodeficiency virus vaccine","volume":"204","author":"L Lai","year":"2011","journal-title":"The Journal of infectious diseases"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1189\/jlb.1204723","article-title":"Disruption of granulocyte macrophage-colony stimulating factor production in the lungs severely affects the ability of mice to control Mycobacterium tuberculosis infection","volume":"77","author":"M Gonzalez-Juarrero","year":"2005","journal-title":"Journal of leukocyte biology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0264-410X(01)00469-8","article-title":"Immune responses to an inactive vaccine against American cutaneous leishmaniasis together with granulocyte-macrophage colony-stimulating factor","volume":"20","author":"I Follador","year":"2002","journal-title":"Vaccine"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrd3220","article-title":"Sipuleucel-T","volume":"9","author":"CS Higano","year":"2010","journal-title":"Nature reviews Drug discovery"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1021\/bi00121a042","article-title":"Role of carbohydrate modification in the production and secretion of human granulocyte macrophage colony-stimulating factor in genetically engineered and normal mesenchymal cells","volume":"31","author":"K Kaushansky","year":"1992","journal-title":"Biochemistry"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/1097-0134(20001001)41:1<144::AID-PROT160>3.0.CO;2-H","article-title":"Secretion of cytoplasmic and nuclear proteins from animal cells using novel secretion modules","volume":"41","author":"PJ Farrell","year":"2000","journal-title":"Proteins"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jim.2012.08.017","article-title":"A simple technique to enhance the humoral immune response to intracellular protein antigens in genetic immunizations","volume":"387","author":"PJ Farrell","year":"2013","journal-title":"Journal of immunological methods"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1242\/jcs.00047","article-title":"Improperly folded green fluorescent protein is secreted via a non-classical pathway","volume":"115","author":"M Tanudji","year":"2002","journal-title":"Journal of cell science"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.exppara.2012.05.002","article-title":"Leishmania donovani recombinant iron superoxide dismutase B1 protein in the presence of TLR-based adjuvants induces partial protection of BALB\/c mice against Leishmania major infection","volume":"131","author":"NS Daifalla","year":"2012","journal-title":"Experimental parasitology"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/CMR.14.2.229-243.2001","article-title":"Leishmaniasis: current status of vaccine development","volume":"14","author":"E Handman","year":"2001","journal-title":"Clinical microbiology reviews"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1365-2249.1997.tb08318.x","article-title":"Biochemical analysis and immunogenicity of Leishmania major amastigote fractions in cutaneous leishmaniasis","volume":"110","author":"S Rafati","year":"1997","journal-title":"Clinical and experimental immunology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e2148","DOI":"10.1371\/journal.pntd.0002148","article-title":"Antigenicity and protective efficacy of a Leishmania amastigote-specific protein, member of the super-oxygenase family, against visceral leishmaniasis","volume":"7","author":"VT Martins","year":"2013","journal-title":"PLoS neglected tropical diseases"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00430-012-0261-2","article-title":"Dendritic cells in Leishmania major infections: mechanisms of parasite uptake, cell activation and evidence for physiological relevance","volume":"201","author":"K Kautz-Neu","year":"2012","journal-title":"Medical microbiology and immunology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1089\/dna.2006.25.438","article-title":"A combined DNA vaccine-prime, BCG-boost strategy results in better protection against Mycobacterium bovis challenge","volume":"25","author":"H Cai","year":"2006","journal-title":"DNA and cell biology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"e14644","DOI":"10.1371\/journal.pone.0014644","article-title":"Potency, efficacy and durability of DNA\/DNA, DNA\/protein and protein\/protein based vaccination using gp63 against Leishmania donovani in BALB\/c mice","volume":"6","author":"S Mazumder","year":"2011","journal-title":"PloS one"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1016\/S0264-410X(00)00020-7","article-title":"Humoral immune responses to DNA vaccines expressing secreted, membrane bound and non-secreted forms of the Tania ovis 45W antigen","volume":"18","author":"DR Drew","year":"2000","journal-title":"Vaccine"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1084\/jem.186.7.1137","article-title":"Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major","volume":"186","author":"S Gurunathan","year":"1997","journal-title":"The Journal of experimental medicine"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1016\/S0264-410X(02)00302-X","article-title":"Protective efficacy of a tandemly linked, multi-subunit recombinant leishmanial vaccine (Leish-111f) formulated in MPL adjuvant","volume":"20","author":"YA Skeiky","year":"2002","journal-title":"Vaccine"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.4049\/jimmunol.145.12.4306","article-title":"Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide","volume":"145","author":"FY Liew","year":"1990","journal-title":"Journal of immunology"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"683485","DOI":"10.1155\/2010\/683485","article-title":"Arginase in parasitic infections: macrophage activation, immunosuppression, and intracellular signals","volume":"2010","author":"CC Stempin","year":"2010","journal-title":"Journal of biomedicine & biotechnology"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major","volume":"13","author":"PA Darrah","year":"2007","journal-title":"Nature medicine"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1128\/CVI.05024-11","article-title":"KSAC, the first defined polyprotein vaccine candidate for visceral leishmaniasis","volume":"18","author":"Y Goto","year":"2011","journal-title":"Clinical and vaccine immunology: CVI"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.4049\/jimmunol.175.4.2517","article-title":"IL-10 from regulatory T cells determines vaccine efficacy in murine Leishmania major infection","volume":"175","author":"CB Stober","year":"2005","journal-title":"Journal of immunology"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.it.2008.09.006","article-title":"New horizons in adjuvants for vaccine development","volume":"30","author":"SG Reed","year":"2009","journal-title":"Trends in immunology"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.exppara.2011.07.001","article-title":"Immunogenicity of Leishmania donovani iron superoxide dismutase B1 and peroxidoxin 4 in BALB\/c mice: the contribution of Toll-like receptor agonists as adjuvant","volume":"129","author":"NS Daifalla","year":"2011","journal-title":"Experimental parasitology"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1600-065X.2010.00980.x","article-title":"DNA vaccines: an historical perspective and view to the future","volume":"239","author":"MA Liu","year":"2011","journal-title":"Immunological reviews"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2172-9-13","article-title":"Coexpression of GM-CSF and antigen in DNA prime-adenoviral vector boost immunization enhances polyfunctional CD8+ T cell responses, whereas expression of GM-CSF antigen fusion protein induces autoimmunity","volume":"9","author":"M Tenbusch","year":"2008","journal-title":"BMC immunology"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1432-1033.2004.03993.x","article-title":"N- and O-linked carbohydrates and glycosylation site occupancy in recombinant human granulocyte-macrophage colony-stimulating factor secreted by a Chinese hamster ovary cell line","volume":"271","author":"G Forno","year":"2004","journal-title":"European journal of biochemistry\/FEBS"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1089\/jir.2009.0053","article-title":"Recombinant mouse granulocyte-macrophage colony-stimulating factor is glycosylated in transgenic tobacco and maintains its biological activity","volume":"30","author":"A Gora-Sochacka","year":"2010","journal-title":"Journal of interferon & cytokine research: the official journal of the International Society for Interferon and Cytokine Research"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1006\/prep.2000.1232","article-title":"Production and characterization of biologically active human GM-CSF secreted by genetically modified plant cells","volume":"19","author":"EA James","year":"2000","journal-title":"Protein expression and purification"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1046\/j.1365-2249.1996.11704.x","article-title":"Production of neutralizing granulocyte-macrophage colony-stimulating factor (GM-CSF) antibodies in carcinoma patients following GM-CSF combination therapy","volume":"104","author":"M Wadhwa","year":"1996","journal-title":"Clinical and experimental immunology"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0014-4894(03)00097-3","article-title":"Expression of cysteine proteinase type I and II of Leishmania infantum and their recognition by sera during canine and human visceral leishmaniasis","volume":"103","author":"S Rafati","year":"2003","journal-title":"Experimental parasitology"}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0003391","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,30]],"date-time":"2023-07-30T16:21:01Z","timestamp":1690734061000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0003391"}},"subtitle":[],"editor":[{"given":"Ricardo Toshio","family":"Fujiwara","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,12,11]]},"references-count":49,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2014,12,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0003391","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,11]]}}}